141 related articles for article (PubMed ID: 1848597)
1. Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction.
Lacey SF; Suzutani T; Powell KL; Purifoy DJ; Honess RW
J Gen Virol; 1991 Mar; 72 ( Pt 3)():623-30. PubMed ID: 1848597
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.
Talarico CL; Phelps WC; Biron KK
J Virol; 1993 Feb; 67(2):1024-33. PubMed ID: 8380452
[TBL] [Abstract][Full Text] [Related]
3. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
Andrei G; De Clercq E; Snoeck R
Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
[TBL] [Abstract][Full Text] [Related]
4. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
[TBL] [Abstract][Full Text] [Related]
7. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R
J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against thymidine kinase negative strains of varicella-zoster virus.
Kawai H; Yoshida I; Suzutani T
Microbiol Immunol; 1993; 37(11):877-82. PubMed ID: 8295566
[TBL] [Abstract][Full Text] [Related]
9. Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV.
Bevilacqua F; Davis-Poynter N; Worrallo J; Gower D; Collins P; Darby G
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1927-35. PubMed ID: 7636473
[TBL] [Abstract][Full Text] [Related]
10. Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Sakuma T
Antimicrob Agents Chemother; 1984 Jun; 25(6):742-6. PubMed ID: 6331298
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.
Morfin F; Thouvenot D; De Turenne-Tessier M; Lina B; Aymard M; Ooka T
Antimicrob Agents Chemother; 1999 Oct; 43(10):2412-6. PubMed ID: 10508017
[TBL] [Abstract][Full Text] [Related]
12. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
13. Random mutagenesis of the thymidine kinase gene of varicella-zoster virus.
Suzutani T; Lacey SF; Powell KL; Purifoy DJ; Honess RW
J Virol; 1992 Apr; 66(4):2118-24. PubMed ID: 1312622
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.
Brunnemann AK; Bohn-Wippert K; Zell R; Henke A; Walther M; Braum O; Maschkowitz G; Fickenscher H; Sauerbrei A; Krumbholz A
Antimicrob Agents Chemother; 2015 May; 59(5):2726-34. PubMed ID: 25712361
[TBL] [Abstract][Full Text] [Related]
15. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants.
Ida M; Kageyama S; Sato H; Kamiyama T; Yamamura J; Kurokawa M; Morohashi M; Shiraki K
Antiviral Res; 1999 Jan; 40(3):155-66. PubMed ID: 10027650
[TBL] [Abstract][Full Text] [Related]
16. Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.
Suzutani T; Saijo M; Nagamine M; Ogasawara M; Azuma M
J Clin Microbiol; 2000 May; 38(5):1839-44. PubMed ID: 10790110
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades.
Hoffmann A; Döring K; Seeger NT; Bühler M; Schacke M; Krumbholz A; Sauerbrei A
J Clin Virol; 2017 Oct; 95():61-65. PubMed ID: 28886462
[TBL] [Abstract][Full Text] [Related]
18. Resistance testing of clinical varicella-zoster virus strains.
Sauerbrei A; Taut J; Zell R; Wutzler P
Antiviral Res; 2011 Jun; 90(3):242-7. PubMed ID: 21539861
[TBL] [Abstract][Full Text] [Related]
19. Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization.
Fillet AM; Dumont B; Caumes E; Visse B; Agut H; Bricaire F; Huraux JM
J Med Virol; 1998 Jul; 55(3):250-4. PubMed ID: 9624615
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mutations in the thymidine kinase gene of varicella zoster virus associated with resistance to 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine.
Kodama E; Mori S; Shigeta S
Antiviral Res; 1995 May; 27(1-2):165-70. PubMed ID: 7486953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]